Who Owns Generate Biomedicines Stock?
NASDAQ: GENBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 82.45%
- Held by insiders
- 14.12%
- Institutional holders
- 139
- Institutions 82.5%
- Insiders 14.1%
- Public and other 3.4%
Who owns Generate Biomedicines stock?
Institutional investors own about 82.5% of Generate Biomedicines's shares, spread across 139 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 14.12% of GENB.
The largest institutional holders are Flagship Pioneering LLC (48.55%), FMR, LLC (5.57%) and Capital World Investors (3.25%). Together, the top 10 institutions control 70.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their GENB positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GENB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Flagship Pioneering LLC | 62.67M | 48.55% | 0.0% |
| FMR, LLC | 7.19M | 5.57% | +37.6% |
| Capital World Investors | 4.20M | 3.25% | -0.3% |
| Braidwell LP | 3.28M | 2.54% | -8.6% |
| JPMORGAN CHASE & CO | 2.65M | 2.06% | +88.3% |
| Vanguard Capital Management LLC | 2.24M | 1.73% | +97.4% |
| Price (T.Rowe) Associates Inc | 2.16M | 1.67% | +2.2% |
| NORGES BANK | 2.09M | 1.62% | +100.0% |
| ARK Investment Management, LLC | 1.96M | 1.52% | +52.9% |
| Arch Venture Management, Llc | 1.94M | 1.51% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GENB
| Fund | Shares | % Held |
|---|---|---|
| SmallCap World Fund Inc | 3.75M | 2.91% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.46M | 1.91% |
| ARK ETF Trust-ARK Genomic Revolution ETF | 1.63M | 1.26% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 816.88K | 0.63% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 763.69K | 0.59% |
| iShares Trust-iShares Russell 2000 ETF | 636.80K | 0.49% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 614.22K | 0.48% |
| JPMorgan Trust II-JPMorgan Small Cap Growth Fund | 580.25K | 0.45% |
| ARK Venture Fund | 409.87K | 0.32% |
| T. Rowe Price Health Sciences Fund, Inc. | 314.96K | 0.24% |
Frequently asked questions
Who is the largest shareholder of Generate Biomedicines?
Flagship Pioneering LLC is the largest institutional shareholder of GENB, owning 48.55% of shares outstanding (62.67M shares) as of its latest 13F filing.
What percentage of Generate Biomedicines is owned by institutions?
Institutions own about 82.5% of GENB shares and 96.0% of the public float.
How much of Generate Biomedicines do insiders own?
Insiders, such as officers and directors, own about 14.12% of GENB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.